Global Spread of Community-Acquired MRSA with PVL Genes
Author Information
Author(s): François Vandenesch, Timothy Naimi, Mark C. Enright, Gerard Lina, Graeme R. Nimmo, Helen Heffernan, Nadia Liassine, Michèle Bes, Timothy Greenland, Marie-Elisabeth Reverdy, Jerome Etienne
Primary Institution: INSERM E0230, Lyon, France
Hypothesis
Does the Panton-Valentine leukocidin (PVL) gene represent a stable marker of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) strains worldwide?
Conclusion
The study found that CA-MRSA strains worldwide share the PVL locus and SCCmec type IV, indicating a common genetic background despite geographic differences.
Supporting Evidence
- All 117 CA-MRSA isolates contained the PVL locus.
- 97% of isolates were of agr type 3.
- Two genes were unique to CA-MRSA isolates shared by isolates from all three continents.
- CA-MRSA isolates were generally susceptible to most antibiotics tested apart from β-lactams.
Takeaway
This study looked at germs that make people sick and found that they are similar all over the world, even if they come from different places.
Methodology
The study analyzed 117 CA-MRSA isolates using polymerase chain reaction for virulence factors and pulsed-field gel electrophoresis for genetic background.
Limitations
The study may not account for all genetic variations of CA-MRSA strains not included in the sample.
Participant Demographics
Isolates were collected from the United States, France, Switzerland, Australia, New Zealand, and Western Samoa.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website